Catechin and quercetin attenuate adipose inflammation in fructose-fed rats and 3T3-L1 adipocytes

Molecular Nutrition and Food Research

Volumn 59, Issue 4, 2015, Pages 622-633

  Vazquez Prieto, Marcela A ^a   Bettaieb, Ahmed ^b   Rodriguez Lanzi, Cecilia ^a   Soto, Verónica C ^a,c   Perdicaro, Diahann J ^a   Galmarini, Claudio R ^a   Haj, Fawaz G ^b,d   Miatello, Roberto M ^a   Oteiza, Patricia I ^b  

^a UNIVERSIDAD NACIONAL DE CUYO   (Argentina)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Inst de Biologia Agricola de Mendoza Consejo Nacional de Investigaciones Cientificas y Tecnicas   (Argentina)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adipokines; Adipose tissue inflammation; Flavonoids; High fructose diet; Metabolic syndrome

Indexed keywords

RATTUS;

ADIPONECTIN; CATECHIN; CCL2 PROTEIN, MOUSE; FRUCTOSE; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; QUERCETIN; RESISTIN; RETN PROTEIN, MOUSE; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR;

3T3 CELL LINE; ADIPOCYTE; ADIPOSE TISSUE; ANIMAL; CHEMICALLY INDUCED; DOWN REGULATION; DRUG EFFECTS; GENETICS; INFLAMMATION; INSULIN RESISTANCE; METABOLISM; MOUSE; PROTEIN CARBONYLATION; RAT; SIGNAL TRANSDUCTION;

3T3-L1 CELLS; ADIPOCYTES; ADIPONECTIN; ADIPOSE TISSUE; ANIMALS; CATECHIN; CHEMOKINE CCL2; DOWN-REGULATION; FRUCTOSE; INFLAMMATION; INSULIN RESISTANCE; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MICE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PPAR GAMMA; PROTEIN CARBONYLATION; QUERCETIN; RATS; RESISTIN; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84926123215     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201400631     Document Type: Article

References (55)

1. Ford, E. S. Giles, W. H. Dietz, W. H. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002, 287, 356-359.
2. Tappy, L. Le, K. A. Metabolic effects of fructose and the worldwide increase in obesity. Physiol. Rev. 2010, 90, 23-46.
3. Cameron, A. J. Shaw, J. E. Zimmet, P. Z. The metabolic syndrome: prevalence in worldwide populations. Endocrinol. Metab. Clin. North Am. 2004, 33, 351-375.
4. Cummings, B. P. Stanhope, K. L. Graham, J. L. Evans, J. L. et al. Dietary fructose accelerates the development of diabetes in UCD-T2DM rats: amelioration by the antioxidant, alpha-lipoic acid. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2010, 298, R1343-R1350.
5. Cox, C. L. Stanhope, K. L. Schwarz, J. M. Graham, J. L. et al. Circulating concentrations of monocyte chemoattractant protein-1, plasminogen activator inhibitor-1, and soluble leukocyte adhesion molecule-1 in overweight/obese men and women consuming fructose- or glucose-sweetened beverages for 10 weeks. J. Clin. Endocrinol. Metab. 2011, 96, E2034-E2038.
6. Vazquez-Prieto, M. A. Rodriguez Lanzi, C. Lembo, C. Galmarini, C. R. et al. Garlic and onion attenuates vascular inflammation and oxidative stress in fructose-fed rats. J. Nutr. Metab. 2011, 2011, 1-7.
7. Bantle, J. P. Dietary fructose and metabolic syndrome and diabetes. J. Nutr. 2009, 139, 1263S-1268S.
8. Pollock, N. K. Bundy, V. Kanto, W. Davis, C. L. et al. Greater fructose consumption is associated with cardiometabolic risk markers and visceral adiposity in adolescents. J. Nutr. 2012, 142, 251-257.
9. Stanhope, K. L. Schwarz, J. M. Keim, N. L. Griffen, S. C. et al. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J. Clin. Invest. 2009, 119, 1322-1334.
10. Vos, M. B. Kimmons, J. E. Gillespie, C. Welsh, J. et al. Dietary fructose consumption among US children and adults: the Third National Health and Nutrition Examination Survey. Medscape J. Med. 2008, 10, 160.
11. Matsuzawa, Y. The metabolic syndrome and adipocytokines. FEBS Lett. 2006, 580, 2917-2921.
12. Gregor, M. F. Hotamisligil, G. S. Inflammatory mechanisms in obesity. Annu. Rev. Immunol. 2011, 29, 415-445.
13. Lefterova, M. I. Haakonsson, A. K. Lazar, M. A. Mandrup, S. PPARgamma and the global map of adipogenesis and beyond. Trends Endocrinol. Metab, 2014, 25, 293-302.
14. Rivera, L. Moron, R. Sanchez, M. Zarzuelo, A. et al. Quercetin ameliorates metabolic syndrome and improves the inflammatory status in obese Zucker rats. Obesity 2008, 16, 2081-2087.
15. Vazquez-Prieto, M. A. Renna, N. F. Diez, E. R. Cacciamani, V. et al. Effect of red wine on adipocytokine expression and vascular alterations in fructose-fed rats. Am. J. Hypertens. 2011, 24, 234-240.
16. Fraga, C. G. Galleano, M. Verstraeten, S. V. Oteiza, P. I. Basic biochemical mechanisms behind the health benefits of polyphenols. Mol. Aspects Med. 2010, 31, 435-445.
17. Beecher, G. R. Overview of dietary flavonoids: nomenclature, occurrence and intake. J. Nutr. 2003, 133, 3248S-3254S.
18. Kleemann, R. Verschuren, L. Morrison, M. Zadelaar, S. et al. Anti-inflammatory, anti-proliferative and anti-atherosclerotic effects of quercetin in human in vitro and in vivo models. Atherosclerosis 2011, 218, 44-52.
19. Nagao, T. Meguro, S. Hase, T. Otsuka, K. et al. A catechin-rich beverage improves obesity and blood glucose control in patients with type 2 diabetes. Obesity 2009, 17, 310-317.
20. Bettaieb, A. Vazquez Prieto, M. A. Rodriguez Lanzi, C. Miatello, R. M. et al. (-)-Epicatechin mitigates high-fructose-associated insulin resistance by modulating redox signaling and endoplasmic reticulum stress. Free Radic. Biol. Med. 2014, 72, 247-256.
21. Vazquez-Prieto, M. A. Bettaieb, A. Haj, F. G. Fraga, C. G. et al. (-)-Epicatechin prevents TNFalpha-induced activation of signaling cascades involved in inflammation and insulin sensitivity in 3T3-L1 adipocytes. Arch. Biochem. Biophys. 2012, 527, 113-118.
22. Panchal, S. K. Poudyal, H. Brown, L. Quercetin ameliorates cardiovascular, hepatic, and metabolic changes in diet-induced metabolic syndrome in rats. J. Nutr. 2012, 142, 1026-1032.
23. Matthews, D. R. Hosker, J. P. Rudenski, A. S. Naylor, B. A. et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28, 412-419.
24. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248-254.
25. Wehr, N. B. Levine, R. L. Quantification of protein carbonylation. Methods Mol. Biol. 2013, 965, 265-281.
26. Henriksen, E. J. Diamond-Stanic, M. K. Marchionne, E. M. Oxidative stress and the etiology of insulin resistance and type 2 diabetes. Free Radic. Biol. Med. 2011, 51, 993-999.
27. Stanhope, K. L. Havel, P. J. Fructose consumption: potential mechanisms for its effects to increase visceral adiposity and induce dyslipidemia and insulin resistance. Curr. Opin. Lipidol. 2008, 19, 16-24.
28. Alzamendi, A. Giovambattista, A. Raschia, A. Madrid, V. et al. Fructose-rich diet-induced abdominal adipose tissue endocrine dysfunction in normal male rats. Endocrine 2009, 35, 227-232.
29. Robubi, A. Huber, K. R. Krugluger, W. Extra fructose in the growth medium fuels lipogenesis of adipocytes. J. Obes. 2014, 2014, 1-6.
30. Kobori, M. Masumoto, S. Akimoto, Y. Oike, H. Chronic dietary intake of quercetin alleviates hepatic fat accumulation associated with consumption of a Western-style diet in C57/BL6J mice. Mol. Nutr. Food Res. 2011, 55, 530-540.
31. Wang, H. Wen, Y. Du, Y. Yan, X. et al. Effects of catechin enriched green tea on body composition. Obesity 2010, 18, 773-779.
32. Stanhope, K. L. Havel, P. J. Endocrine and metabolic effects of consuming beverages sweetened with fructose, glucose, sucrose, or high-fructose corn syrup. Am. J. Clin. Nutr. 2008, 88, 1733S-1737S.
33. Muramatsu, K. Fukuyo, M. Hara, Y. Effect of green tea catechins on plasma cholesterol level in cholesterol-fed rats. J. Nutr. Sci. Vitaminol. 1986, 32, 613-622.
34. Grove, K. A. Lambert, J. D. Laboratory, epidemiological, and human intervention studies show that tea (Camellia sinensis) may be useful in the prevention of obesity. J. Nutr. 2010, 140, 446-453.
35. Galleano, M. Calabro, V. Prince, P. D. Litterio, M. C. et al. Flavonoids and metabolic syndrome. Ann. N Y Acad. Sci. 2012, 1259, 87-94.
36. Babu, P. V. Liu, D. Gilbert, E. R. Recent advances in understanding the anti-diabetic actions of dietary flavonoids. J. Nutr. Biochem. 2013, 24, 1777-1789.
37. Osborn, O. Olefsky, J. M. The cellular and signaling networks linking the immune system and metabolism in disease. Nat. Med. 2012, 18, 363-374.
38. Rajala, M. W. Qi, Y. Patel, H. R. Takahashi, N. et al. Regulation of resistin expression and circulating levels in obesity, diabetes, and fasting. Diabetes 2004, 53, 1671-1679.
39. Menzaghi, C. Bacci, S. Salvemini, L. Mendonca, C. et al. Serum resistin, cardiovascular disease and all-cause mortality in patients with type 2 diabetes. PLoS One 2013, 8, e64729.
40. Fukuhara, A. Matsuda, M. Nishizawa, M. Segawa, K. et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005, 307, 426-430.
41. Romacho, T. Azcutia, V. Vazquez-Bella, M. Matesanz, N. et al. Extracellular PBEF/NAMPT/visfatin activates pro-inflammatory signalling in human vascular smooth muscle cells through nicotinamide phosphoribosyltransferase activity. Diabetologia 2009, 52, 2455-2463.
42. Lim, S. Y. Davidson, S. M. Paramanathan, A. J. Smith, C. C. et al. The novel adipocytokine visfatin exerts direct cardioprotective effects. J. Cell. Mol. Med. 2008, 12, 1395-1403.
43. Hirosumi, J. Tuncman, G. Chang, L. Gorgun, C. Z. et al. A central role for JNK in obesity and insulin resistance. Nature 2002, 420, 333-336.
44. Aguirre, V. Uchida, T. Yenush, L. Davis, R. et al. The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J. Biol. Chem. 2000, 275, 9047-9054.
45. Chuang, C. C. Martinez, K. Xie, G. Kennedy, A. et al. Quercetin is equally or more effective than resveratrol in attenuating tumor necrosis factor-{alpha}-mediated inflammation and insulin resistance in primary human adipocytes. Am. J. Clin. Nutr. 2010, 92, 1511-1521.
46. Hotamisligil, G. S. Shargill, N. S. Spiegelman, B. M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993, 259, 87-91.
47. Carvalho, C. R. Bueno, A. A. Mattos, A. M. Biz, C. et al. Fructose alters adiponectin, haptoglobin and angiotensinogen gene expression in 3T3-L1 adipocytes. Nutr. Res. 2010, 30, 644-649.
48. Wellen, K. E. Hotamisligil, G. S. Inflammation, stress, and diabetes. J. Clin. Invest. 2005, 115, 1111-1119.
49. Cho, S. Y. Park, P. J. Shin, H. J. Kim, Y. K. et al. (-)-Catechin suppresses expression of Kruppel-like factor 7 and increases expression and secretion of adiponectin protein in 3T3-L1 cells. Am. J. Physiol. Endocrinol. Metab. 2007, 292, E1166-E1172.
50. Wang, S. Moustaid-Moussa, N. Chen, L. Mo, H. et al. Novel insights of dietary polyphenols and obesity. J. Nutr. Biochem. 2014, 25, 1-18.
51. Wein, S. Behm, N. Petersen, R. K. Kristiansen, K. et al. Quercetin enhances adiponectin secretion by a PPAR-gamma independent mechanism. Eur. J. Pharm. Sci. 2010, 41, 16-22.
52. Pignatelli, P. Pulcinelli, F. M. Celestini, A. Lenti, L. et al. The flavonoids quercetin and catechin synergistically inhibit platelet function by antagonizing the intracellular production of hydrogen peroxide. Am. J. Clin. Nutr. 2000, 72, 1150-1155.
53. Redondo, A. Estrella, N. Lorenzo, A. G. Cruzado, M. et al. Quercetin and catechin synergistically inhibit angiotensin II-induced redox-dependent signalling pathways in vascular smooth muscle cells from hypertensive rats. Free Radic. Res. 2012, 46, 619-627.
54. Menendez, C. Jimenez, R. Moreno, L. Galindo, P. et al. Lack of synergistic interaction between quercetin and catechin in systemic and pulmonary vascular smooth muscle. Br. J. Nutr. 2011, 105, 1287-1293.
55. Delgado, L. Fernandes, I. Gonzalez-Manzano, S. deFreitas, V. et al. Anti-proliferative effects of quercetin and catechin metabolites. Food Funct. 2014, 5, 797-803.